Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125608531 | 12560853 | 1 | I | 20160704 | 20160715 | 20160715 | EXP | US-WATSON-2016-15271 | WATSON | QAQISH I, SCHLAM IM, CHAKKERA HA, FONSECA R, ADAMSKI J. CARFILZOMIB: A CAUSE OF DRUG ASSOCIATED THROMBOTIC MICROANGIOPATHY. TRANSFUS APHERESIS SCI. 2016;54(3):401-4. | 72.00 | YR | F | Y | 0.00000 | 20160715 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125608531 | 12560853 | 1 | PS | Dexamethasone (Watson Laboratories) | DEXAMETHASONE | 1 | Unknown | UNK | UNCONFIRMED | 85456 | UNK | ||||||||
| 125608531 | 12560853 | 2 | SS | LENALIDOMIDE | LENALIDOMIDE | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125608531 | 12560853 | 1 | Plasma cell myeloma |
| 125608531 | 12560853 | 2 | Plasma cell myeloma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125608531 | 12560853 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125608531 | 12560853 | Pneumonia | |
| 125608531 | 12560853 | Syncope | |
| 125608531 | 12560853 | Vitreous haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |